Phagocyte‐derived oxidants and plasma antioxidants in haemodialysed patients

References

• Sarnak M. J., Jaber B. L. Mortality caused by sepsis in patients with end‐stage renal disease compared with the general population. Kidney Int 2000; 58: 1758–64
   PubMed Web of Science ®Google Scholar
• Ward R. M., McLeish K. R. Oxidant stress in hemodialysis patients: What are the determinating factors?. Artif Organs 2003; 27: 230–6
   PubMed Web of Science ®Google Scholar
• Siems W., Quast S., Carluccio F., Wiswedel I., Hirsch D., Augustin W., et al. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 2002; 58 Suppl 1: S12–19
   Google Scholar
• Kormoczi G. F., Rosenkranz A. R., Zlabinger G. J. Polymorphonuclear granulocyte stimulation by cellulose‐based hemodialysis membranes. Clin Chem Lab Med 1999; 37: 351–5
   PubMed Web of Science ®Google Scholar
• Eiselt J., Racek J., Opatrny K., Jr. Free radicals and extracorporeal renal replacement therapy. Vnitr Lek 1999; 45: 319–24
   PubMedGoogle Scholar
• Erdogan C., Unlucerci Y., Turkmen A., Kuru A., Cetin O., Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002; 322: 157–61
   PubMed Web of Science ®Google Scholar
• Pavelkova M., Kubala L. Luminol‐, isoluminol‐ and lucigenin‐enhanced chemiluminescence of rat blood phagocytes stimulated with different activators. Luminescence 2004; 19: 37–42
   PubMed Web of Science ®Google Scholar
• Slavíková H., Lojek A., Hamar J., Dušková M., Kubala L., Vondráček J., et al. Total antioxidant capacity of serum increased in early but not late period after intestinal ischemia in rats. Free Radic Biol Med 1998; 25: 9–18
   PubMed Web of Science ®Google Scholar
• Urban T., Hurbain I., Urban M., Clement A., Housset R. Oxidants and antioxidants. Biological effects and therapeutic perspective. Ann Chir 1995; 49: 427–34
   PubMedGoogle Scholar
• Witko‐Sarsat V., Rieu P., Descamps‐Latscha B., Lesavre P., Halbwachs‐Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80: 617–53
   PubMed Web of Science ®Google Scholar
• Perianayagam M. C., Morena M., Jaber B. L., Balakrishnan V. S. Anti‐oxidants reverse uraemia‐induced down‐regulation of mitochondrial membrane potential and interleukin‐10 production. Eur J Clin Invest 2005; 35: 148–53
   PubMedGoogle Scholar
• Vanholder R., Schepers E., Meert N., Lameire N. What is uremia? Retention versus oxidation. Blood Purif 2006; 24: 33–8
   PubMed Web of Science ®Google Scholar
• Glorieux G. L., Dhondt A. W., Jacobs P., Van Langeraert J., Lameire N. H., De Deyn P. P., et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004; 65: 2184–92
   PubMed Web of Science ®Google Scholar
• Himmelfarb J., Ault K. A., Holbrook D., Leeber D. A., Hakim R. M. Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Cos Nephro 1993; 4: 178–86
   PubMed Web of Science ®Google Scholar
• Vanholder R., Ringoir S., Dhondt A., Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320–7
   PubMed Web of Science ®Google Scholar
• Descamps‐Latscha B., Goldfarb B., Nguyen A. T., Landais P., London G., Haeffner‐Cavaillon N., et al. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron 1991; 59: 279–85
   PubMed Web of Science ®Google Scholar
• Lojek A., Cerný J., Nemec P., Nicovsky J., Soska V., Ciz M., et al. Phagocyte‐induced oxidative stress in patients with haemodialysis treatment and organ transplantation. BioFactors 1998; 8: 165–8
   PubMedGoogle Scholar
• Haag‐Weber M., Schollmeyer P., Horl W. H. Neutrophil activation during hemodialysis. Adv Exp Med Biol 1989; 260: 27–37
   PubMedGoogle Scholar
• Horl W. H., Steinhauer H. B., Schollmeyer P. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 1985; 28: 791–6
   PubMedGoogle Scholar
• Cohen M. S., Elliott D. M., Chplinski T., Pike M. M., Niedel J. E. A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. Blood 1982; 60: 1283–9
   PubMedGoogle Scholar
• Sela S., Shurtz‐Swirski R., Shapiro G., Nasser L., Hamzi M., Shasha S. M., et al. Oxidative stress during hemodialysis: effect of heparin. Kidney Int Suppl 2001; 78: S159–63
   Google Scholar
• Himmelfarb J., Mcmonagle E., Holbrook D., Toth C. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 1995; 126: 392–400
   PubMedGoogle Scholar
• Jackson P., Loughrey C. M., Lightbody J. H., McNamee P. T., Young I. S. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135–8
   PubMed Web of Science ®Google Scholar
• Prakash M., Upadhya S., Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Scand J Clin Lab Invest 2004; 64: 599–604
   PubMed Web of Science ®Google Scholar
• Alhamdani M. S. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant 2005; 20: 124–8
   PubMed Web of Science ®Google Scholar
• Alhamdani M. S., Al‐Najjar A. F., Al‐Kassir A. H. The effect of hemodialysis and dialyzer biocompatibility on erythrocyte glutathione‐defense system in chronic hemodialysis patients. Int J Artif Organs 2005; 8: 576–82
   Google Scholar
• Bergesio F., Monzani G., Ciuti R., Pinzani P., Fiaschi N., Priami F., et al. Total antioxidant capacity: is it an effective method to evaluate the oxidative stress in uraemia?. J Biolumin Chemilumin 1998; 13: 315–19
   PubMedGoogle Scholar
• Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000; 46: 1723–7
   PubMed Web of Science ®Google Scholar
• Schettler V., Kuhn W., Kleinoeder T., Armstrong V. W., Oellerich M., Muller G. A., et al. No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells. J Intern Med 2003; 253: 201–17
   PubMedGoogle Scholar
• Dursum E., Ozben T., Süleymanlar G., Dursun B., Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002; 40: 1009–13
   PubMedGoogle Scholar